Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age

Ophthalmology

Volumn 109, Issue 1, 2002, Pages 126-131

  Lahey, J Michael ^a   Tunç, Murat ^a,b   Kearney, John ^a   Modlinski, Barbara ^a   Koo, Howard ^c   Johnson, Robert N ^d   Tanaka, Stephen ^a  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^c Regional Laboratory   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; CARDIOLIPIN ANTIBODY; GLUCOSE; HOMOCYSTEINE; LIPID; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD CELL COUNT; BLOOD PRESSURE MEASUREMENT; CENTRAL RETINA VEIN OCCLUSION; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; INCIDENCE; INTRAOCULAR PRESSURE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOGENESIS; THROMBOPHILIA;

ACTIVATED PROTEIN C RESISTANCE; ADULT; BLOOD CELL COUNT; BLOOD GLUCOSE; BLOOD PRESSURE; FACTOR V; FEMALE; HOMOCYSTEINE; HUMANS; INTRAOCULAR PRESSURE; LIPIDS; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN C; PROTEIN S; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; THROMBOPHILIA;

EID: 0036135672     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(01)00842-9     Document Type: Article

References (38)

1. Evaluation of a patient with central retinal vein occlusion
2. Central retinal vein occlusion in young adults
3. The natural course of central retinal vein occlusion
4. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: A population controlled study
5. B-thromboglobulin and platelet factor 4 levels in retinal vein occlusion
6. Retinal vein occlusion and prevelance of lipoprotein abnormalities
7. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion
8. Prevelance and patient profile in activated protein C resistance
9. Hypercoagulability and thrombosis
10. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
11. Antiphos pholipid antibodies, haemostatic variables and thrombosis - A survey of 144 patients
12. Thermolabile 5, 10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia
13. Hyperhomo cysteinemia in retinal artery and retinal vein occlusion
14. Retinal vein occlusion and transient monocular visual loss associated with hyperhomocysteinemia
15. Unpredictable intra-individual variations in serum homocysteine levels on folic acid supplementation
16. Antithrombin III deficiency and thromboembolism
17. Prothrombotic states associated with retinal venous occlusion in young adults
18. Protein C, protein S, and antithrombin III in acute ocular occlusive diseases
19. Retinaler gefässverschluss bei antithrombin III-mangel
20. Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion
21. Inhibitoren der gerinnung bei gefässver schlüssen der netzhaut und des sehnerven
22. Normal activities of protein C protein S and antithrombin III in young patients with retinal vein occlusion
23. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia study
24. Factor V Leiden (FVQ 506) is common in a Brazilian population
25. Risk factors in central retinal vein occlusion and activated protein C resistance
26. Peripheral retinal neovascularization and retinal vascular occlusion associated with activated protein C resistance
27. Activated protein C resistance in young adults with central retinal vein occlusion
28. Factor V Leiden, activated protein C resistance, and retinal vein occlusion
29. Activated protein C resistance, factor V Leiden, and central retinal vein occlusion in young adults
30. Factor V and antithrombin gene mutations in patients with idiopathic central retinal vein occlusion
31. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect
32. Occlusion ischémique de la veine centrale de la rétine et déficit en protéine C
33. Occlusion veineuse de la rétine et résistance à la protéine C activée
34. Acquired protein S deficiency in a patient with systemic lupus erythematosus causing central retinal vein thrombosis
35. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: A prospective cohort study
36. The clinico-ophthalmological spectrum of antiphospholipid syndrome
37. Antiphospholipid antibodies and retinal vascular disease
38. Antiphospholipidprotein antibodies are not an uncommon feature in retinal venous occlusions